However, the fact that all four patients with significantly increased granzyme B in the tumor periphery showed rapid disease progression and succumbed to ccRCC may point to the development of aggressive, apoptosis-resistant subclones under selection pressure from a high number of non-exhausted T cells. The gene discussed is GZMB; the disease is nonpapillary renal cell carcinoma.